1
|
Casco N, Jorge AL, Palmero D, Alffenaar JW, Fox G, Ezz W, Cho JG, Skrahina A, Solodovnikova V, Bachez P, Arbex MA, Galvão T, Rabahi M, Pereira GR, Sales R, Silva DR, Saffie MM, Miranda RC, Cancino V, Carbonell M, Cisterna C, Concha C, Cruz A, Salinas NE, Revillot ME, Farias J, Fernandez I, Flores X, Gallegos P, Garavagno A, Guajardo C, Bahamondes MH, Merino LM, Muñoz E, Muñoz C, Navarro I, Navarro J, Ortega C, Palma S, Pardenas AM, Pereira G, Castillo PP, Pinto M, Pizarro R, Rivas F, Rodriguez P, Sánchez C, Serrano A, Soto A, Taiba C, Venegas M, Vergara MS, Vilca E, Villalon C, Yucra E, Li Y, Cruz A, Guelvez B, Plaza R, Tello K, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Gupta N, Ish P, Mishra G, Sharma S, Singla R, Udwadia ZF, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Alladio F, Calcagno A, Centis R, Codecasa LR, D Ambrosio L, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Kuksa L, Danila E, Diktanas S, Miliauskas S, Ridaura RL, López F, Torrico MM, Rendon A, Akkerman OW, Piubello A, Souleymane MB, Aizpurua E, Gonzales R, Jurado J, Loban A, Aguirre S, de Egea V, Irala S, Medina A, Sequera G, Sosa N, Vázquez F, Manga S, Villanueva R, Araujo D, Duarte R, Marques TS, Grecu VI, Socaci A, Barkanova O, Bogorodskaya M, Borisov S, Mariandyshev A, Kaluzhenina A, Stosic M, Beh D, Ng D, Ong C, Solovic I, Dheda D, Gina P, Caminero JA, Cardoso-Landivar J, de Souza Galvão ML, Dominguez-Castellano A, García-García JM, Pinargote IM, Fernandez SQ, Sánchez-Montalvá A, Huguet ET, Murguiondo MZ, Bruchfeld J, Bart PA, Mazza-Stalder J, Tiberi S, Arrieta F, Heysell S, Logsdon J, Young L. TB and COVID-19 co-infection: rationale and aims of a global study. Int J Tuberc Lung Dis 2021; 25:78-80. [PMID: 33384052 DOI: 10.5588/ijtld.20.0786] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
| | | | | | | | - G Fox
- New South Wales, Australia
| | - W Ezz
- New South Wales, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Andréjak C, Barras E. [Interferon gamma release assay tests and nontuberculous mycobacteria]. Rev Mal Respir 2018; 35:900-901. [PMID: 30220488 DOI: 10.1016/j.rmr.2018.08.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2017] [Accepted: 03/21/2018] [Indexed: 10/28/2022]
Affiliation(s)
- C Andréjak
- Service de pneumologie et réanimation, CHU Amiens Picardie, université Picardie Jules-Verne, EA 4294, 80054 Amiens cedex 1, France.
| | - E Barras
- Service de pneumologie et réanimation, CHU Amiens Picardie, université Picardie Jules-Verne, EA 4294, 80054 Amiens cedex 1, France
| |
Collapse
|
3
|
Bergot E, Abiteboul D, Andréjak C, Antoun F, Barras E, Blanc FX, Bourgarit A, Charlois-Ou C, Delacourt C, Dirou S, Gerin M, Guerin S, Haustraete É, Henry B, Lucet JC, Maitre T, Morin J, Le Palud P, Pommelet V, Rivoisy C, Robert J, Veziris N, Herrmann JL. [Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis]. Rev Mal Respir 2018; 35:852-858. [PMID: 30224215 DOI: 10.1016/j.rmr.2018.08.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2017] [Accepted: 03/21/2018] [Indexed: 11/29/2022]
Affiliation(s)
- E Bergot
- Service de pneumologie, CHRU Côte de Nacre, 14033 Caen, France
| | - D Abiteboul
- Groupe d'étude sur le risque d'exposition de soignants aux agents infectieux (GERES), UFR de Médecine-site Bichat, 75018 Paris, France
| | - C Andréjak
- Service de pneumologie et réanimation, CHU Amiens Picardie, université Picardie Jules Verne, EA 4294, 80054 Amiens cedex 1, France
| | - F Antoun
- Département de Paris, centre de lutte anti tuberculeuse, direction de l'action sociale de l'enfance et de la santé, 75013 Paris, France
| | - E Barras
- Service de pneumologie et réanimation, CHU Amiens Picardie, université Picardie Jules Verne, EA 4294, 80054 Amiens cedex 1, France
| | - F-X Blanc
- Service de pneumologie, l'institut du thorax, CHU de Nantes, université de Nantes, 44093 Nantes cedex 1, France
| | - A Bourgarit
- Service de médecine interne, hôpital Jean Verdier, AP-HP, HUPSSD, 93140 Bondy, France; Inserm UMR 1149 CRI, université Paris 13, SmBH, 93140 Bondy, France
| | - C Charlois-Ou
- Département de Paris, centre de lutte anti tuberculeuse, direction de l'action sociale de l'enfance et de la santé, 75013 Paris, France
| | - C Delacourt
- Hôpital Necker-Enfants Malades, AP-HP, 75015 Paris, France
| | - S Dirou
- Service de pneumologie, l'institut du thorax, CHU de Nantes, université de Nantes, 44093 Nantes cedex 1, France
| | - M Gerin
- Inserm UMR 1149 CRI, université Paris 13, SmBH, 93140 Bondy, France
| | - S Guerin
- Hôpital Necker-Enfants Malades, AP-HP, 75015 Paris, France
| | - É Haustraete
- Service de Pneumologie, centre hospitalier Robert Bisson, 14107 Lisieux, France
| | - B Henry
- Service des maladies infectieuses et tropicales, centre d'infectiologie Necker Pasteur, hôpital Necker Enfants Malades, AP-HP, 75015 Paris, France; Institut Imagine, université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France
| | - J-C Lucet
- Unité d'hygiène de et de lutte contre l'infection nosocomiale (UHLIN), GH Bichat-Claude Bernard, AP-HP , 75877 Paris, France
| | - T Maitre
- Inserm, U1135, centre d'immunologie et des maladies infectieuses, Sorbonne universités, Sorbonne université, 75013 Paris, France
| | - J Morin
- Service de pneumologie, l'institut du thorax, CHU de Nantes, université de Nantes, 44093 Nantes cedex 1, France
| | - P Le Palud
- Service de pneumologie, CHRU Côte de Nacre, 14033 Caen, France
| | - V Pommelet
- Service de pédiatrie générale, hôpital Robert-Debré, AP-HP, 75019 Paris, France
| | - C Rivoisy
- Service de médecine interne, hôpital Jean Verdier, AP-HP, HUPSSD, 93140 Bondy, France
| | - J Robert
- Inserm, U1135, centre d'immunologie et des maladies infectieuses, Sorbonne universités, Sorbonne université, 75013 Paris, France; Laboratoire de bactériologie-hygiène, hôpital Pitié-Salpêtrière, centre national de référence des mycobactéries et de la résistance des mycobactéries aux antituberculeux, AP-HP, 75013 Paris, France
| | - N Veziris
- Inserm, U1135, centre d'immunologie et des maladies infectieuses, Sorbonne universités, Sorbonne université, 75013 Paris, France; Département de bactériologie, hôpitaux universitaires de l'Est Parisien, centre national de référence des mycobactéries, AP-HP, 75012, Paris, France
| | - J-L Herrmann
- Laboratoire de bactériologie-hygiène, GHU hôpitaux Ile de France-Ouest, hôpital Raymond Poincaré, AP-HP, 92380 Garches, France; UMR1173, Inserm, université de Versailles Saint Quentin, UFR des sciences de la santé, 78180 Montigny le Bretonneux, France.
| |
Collapse
|
4
|
Balavoine C, Andréjak C, Marchand-Adam S, Blanc F. Relations entre la BPCO et les infections à mycobactéries non tuberculeuses. Rev Mal Respir 2017; 34:1091-1097. [DOI: 10.1016/j.rmr.2017.09.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2016] [Accepted: 11/18/2016] [Indexed: 01/15/2023]
|
5
|
Huet D, Godbert B, Hermann J, Zordan JM, Chabot F, Andréjak C. [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. Rev Mal Respir 2016; 34:257-261. [PMID: 27639948 DOI: 10.1016/j.rmr.2016.05.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2015] [Accepted: 05/28/2016] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Pulmonary infection due to Mycobacterium malmoense can be difficult to diagnose. These difficulties can be responsible for a delay in the implementation of optimal treatment. Moreover, the treatment is not standardized. OBSERVATION We report the case of a 56-year-old patient who developed a Mycobacterium malmoense pulmonary infection whose diagnosis was delayed due to initial suspicion of pulmonary Mycobacterium tuberculosis infection. Once the diagnosis was confirmed, the patient was treated empirically with rifampicin, ethambutol, and clarithromycin for 12 months after culture conversion, giving a total of 15 months. The clinical and radiological outcomes were favorable. DISCUSSION This clinical case highlights the difficulties of diagnosing pulmonary atypical mycobacterial infection according to the American Thoracic Society criteria, particularly Mycobacterium malmoense, a non-tuberculous mycobacterium (NTM) quite uncommon in France. Currently, there are new diagnostic techniques such as GenoType Mycobacteria Direct®. The second issue is the poorly standardized treatment of this NTM and many others, that are based on the recommendations of the British Thoracic Society. A national register has been set up by the MycoMed network, based essentially on the work of microbiologists but this register is unfortunately not exhaustive. CONCLUSION A more systematic reporting strategy could allow cohort studies and therefore provide us with data on the most efficient drugs in the treatment of the rarest NTM infections.
Collapse
Affiliation(s)
- D Huet
- CHRU de Nancy, bâtiment des spécialités médicales Philippe Cantion, rue du Morvan, 54511 Vandoeuvre-les-Nancy cedex, France.
| | - B Godbert
- Service de pneumologie, hôpital Robert-Schuman, 57070 Vantoux, France
| | - J Hermann
- Service de pneumologie, hôpital Robert-Schuman, 57070 Vantoux, France
| | - J-M Zordan
- Service de pneumologie, hôpital Robert-Schuman, 57070 Vantoux, France
| | - F Chabot
- CHRU de Nancy, bâtiment des spécialités médicales Philippe Cantion, rue du Morvan, 54511 Vandoeuvre-les-Nancy cedex, France
| | - C Andréjak
- Service de pneumologie et de réanimation respiratoire, CHU Sud, 80080 Amiens, France
| |
Collapse
|
6
|
Andréjak C, Roger PA, Monconduit J, Jounieaux V. Place de la ventilation non invasive dans l’asthme aigu grave. Réanimation 2016. [DOI: 10.1007/s13546-015-1159-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
7
|
Lecerf C, Lagrange A, Douadi Y, Jounieaux V, Andréjak C. Facteurs prédictifs de longue positivité des prélèvements bactériologiques en cas de tuberculose pulmonaire. Rev Mal Respir 2014. [DOI: 10.1016/j.rmr.2013.10.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
8
|
Andréjak C, Peuchant O, Véziris N, Segonds C, Terru D, Hamdad F, Lagrange A, Lalande V, Bemer P. Devenir et pronostic des infections pulmonaires à mycobactéries non tuberculeuses en France. Rev Mal Respir 2014. [DOI: 10.1016/j.rmr.2013.10.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
9
|
Lagrange A, Andréjak C, Lecerf C, Jounieaux V. À propos d’une épidémie de Klebsiella pneumoniae multirésistante en réanimation respiratoire. Rev Mal Respir 2013. [DOI: 10.1016/j.rmr.2012.10.406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Lenel S, Andréjak C, Monconduit J, Jounieaux V. Survie et facteurs pronostiques des patients BPCO au décours d’un premier épisode de décompensation respiratoire aiguë nécessitant une ventilation mécanique invasive. Rev Mal Respir 2013. [DOI: 10.1016/j.rmr.2012.10.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
11
|
Abstract
The incidence of bronchiectasis has declined significantly in industrialized countries and its management has also changed because of the progress of antibiotic therapy. However, for some patients, medical treatment is not sufficient to control the disease and the quality of life is affected. Surgical treatment is then a very good alternative, when a gesture of complete resection of the affected areas is feasible in terms of lung function and it allows, with a low morbidity and mortality, for very satisfactory long-term results and slows down the progression of the disease. In cases of diffuse and inhomogeneous bronchiectasis, a gesture of incomplete resection of cystic, non-perfused and suppurative areas improves symptoms and reduces recurrent infections. When the bronchiectasis is diffuse, but homogeneous, associated with severe respiratory failure, lung transplantation should be considered. Therefore, surgery remains important in the management of bronchiectasis. Its indications and the lung resection gesture to achieve should be discussed based on the symptoms, imaging examinations and the lung function of the patient.
Collapse
Affiliation(s)
- F De Dominicis
- Service de chirurgie thoracique, hôpital Sud, CHU d'Amiens, université de Picardie, avenue René-Laennec, Amiens cedex 1, France
| | | | | | | | | |
Collapse
|
12
|
Rault I, Jounieaux V, Andréjak C. Exacerbation infectieuse à Pseudomonas aeruginosa chez le patient BPCO. Rev Mal Respir 2012. [DOI: 10.1016/j.rmr.2011.10.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Andréjak C, Véziris N, Lescure X, Cadranel J, Jounieaux V. Essai CaMoMy : évaluation de la capacité de deux schémas thérapeutiques (Clarithromycine ou Moxifloxacine) à négativer les cultures à six mois de malades porteurs d’une infection pulmonaire à Mycobacterium xenopi. PHRC national 2010. Rev Mal Respir 2012. [DOI: 10.1016/j.rmr.2011.10.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
14
|
Andréjak C, Lescure FX, Schmit JL, Jounieaux V. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract]. Rev Mal Respir 2011; 28:1293-309. [PMID: 22152937 DOI: 10.1016/j.rmr.2011.02.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2010] [Accepted: 02/28/2011] [Indexed: 01/15/2023]
Abstract
INTRODUCTION Non tuberculous mycobacteria (NTM), unlike tuberculous mycobacteria, are not strictly human pathogens. The diagnosis of infection and the choice of treatment remain difficult. BACKGROUND Evidence of a NTM in a pulmonary sample is not synonymous with infection. The diagnosis depends on the association of clinical, radiological and microbiological factors. If a NTM is isolated from a respiratory sample, the probability of infection depends on the species. The main NTMs responsible for pulmonary infection in France are Mycobacterium avium intracellulare, Mycobacterium xenopi, Mycobacterium kansasi and Mycobacterium abscessus. Their management is difficult and poorly understood. Treatment is well established for M. avium intracellulare and M. kansasii, with combinations of clarithromycin-rifampicin-ethambutol and isoniazid-rifampicin-ethambutol respectively. For M. xenopi, the optimal treatment is not known and a combination of clarithromycin-rifampicin-ethambutol, with moxifloxacin as an alternative, is currently recommended. In general, treatment is prolonged and often associated with problems of tolerance. VIEWPOINT AND CONCLUSION The management of NTM infection, taking into account of the increase in patients "at risk", is an important issue. Further studies are needed to improve the criteria for infection and to find the optimal therapeutic combinations.
Collapse
Affiliation(s)
- C Andréjak
- Service de pneumologie et réanimation respiratoire, CHU d'Amiens, avenue Laënnec, Amiens cedex 1, France.
| | | | | | | |
Collapse
|
15
|
Gosset M, Andréjak C, Magois E, Aubry P, Mayeux I, Toublanc B, Ammenouche N, Carmi D, Renard C, Jounieaux V. [Dyspnea with fever]. Rev Mal Respir 2009; 26:1011-3. [PMID: 19953051 DOI: 10.1016/s0761-8425(09)73340-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- M Gosset
- Service de Pneumologie et réanimation respiratoire, Centre Hospitalier Universitaire Sud, Amiens, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Andréjak C, Lescure FX, Pukenyte E, Douadi Y, Yazdanpanah Y, Laurans G, Schmit JL, Jounieaux V. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 2008; 64:291-6. [PMID: 19052044 DOI: 10.1136/thx.2008.096842] [Citation(s) in RCA: 67] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Owing to its low incidence, the management of Mycobacterium xenopi pulmonary infections is not clearly defined. A multicentre retrospective study was performed to describe the features of the disease and to evaluate its prognosis. METHODS All patients with M xenopi satisfying the 1997 ATS/IDSA criteria from 13 hospitals in north-east France (1983-2003) were included in the study. Clinical, radiological and bacteriological characteristics and data on the management and outcome were collected. RESULTS 136 patients were included in the analysis, only 12 of whom presented with no co-morbidity. Three types of the disease were identified: (1) a classical cavitary form in patients with pre-existing pulmonary disease (n = 39, 31%); (2) a solitary nodular form in immunocompetent patients (n = 41, 33%) and (3) an acute infiltrate form in immunosuppressed patients (n = 45, 36%). 56 patients did not receive any treatment; the other 80 patients received first-line treatment containing rifamycin (87.5%), ethambutol (75%), isoniazid (66.2%), clarithromycin (30%) or fluoroquinolones (21%). After a follow-up of 36 months, 80 patients (69.1%) had died; the median survival was 16 months (range 10-22). Two independent prognostic factors were found: the acute infiltrate form was associated with a bad prognosis (hazard ratio 2.6, p = 0.001) and rifamycin-containing regimens provided protection (hazard ratio 0.325, p = 0.006). Clarithromycin-containing regimens did not improve the prognosis. CONCLUSIONS In contrast to recent guidelines, this study showed three different types of the disease (cavitary, nodular or diffuse infiltrate forms) with a different prognosis. In order to improve survival, all patients with M xenopi infection should be treated with a rifamycin-containing regimen. The usefulness of clarithromycin remains to be evaluated.
Collapse
Affiliation(s)
- C Andréjak
- Pneumology Department, Teaching Hospital Amiens, Amiens, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Parrot A, Khalil A, Roques S, Andréjak C, Savale L, Carette MF, Mayaud C, Bazelly B, Fartoukh M. [Management of severe hemoptysis: experience in a specialized center]. Rev Pneumol Clin 2007; 63:202-10. [PMID: 17675944 DOI: 10.1016/s0761-8417(07)90125-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
Bronchiectasis, cancer and tuberculosis account for the majority of haemoptysis requiring intensive care unit admission. Bedside evaluation (volume and bronchoscopic active bleeding) is safe to screen patients for arteriography and bronchial artery embolisation (BAE). First-line interventional arteriography should be favour over surgery in patients with non traumatic life-threatening hemoptysis. Surgery must be reserved in cases of failure or recurrence of bleeding after BAE.
Collapse
Affiliation(s)
- A Parrot
- Service de Pneumologie et Unité de Réanimation, Hôpital Tenon, AP-HP, 4, rue de la Chine, 75970 Paris Cedex 20
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Andréjak C, Bazelly B, Prigent H, Parrot A, Stoclin A, Khalil A, Fartoukh M. 39 Place de la chirurgie dans la prise en charge des hémoptysies graves admises en réanimation. Rev Mal Respir 2007. [DOI: 10.1016/s0761-8425(07)72414-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
19
|
Andréjak C, Lescure FX, Pluquet E, Laurans G, Lecuyer E, Schmit JL, Jounieaux V, Dayen C, Douadi Y. A-13 Infections pulmonaires à mycobactéries atypiques. Étude sur 31 cas et revue de la littérature. Med Mal Infect 2004. [DOI: 10.1016/s0399-077x(04)90108-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|